rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2003-8-20
|
pubmed:abstractText |
Injection drug users (IDUs) are at high-risk for hepatitis B virus (HBV) and HIV. Due to concerns about non-adherence to multi-dose vaccine regimens however, IDUs are severely under-immunized against HBV and have been excluded from phase III trials of multi-dose candidate HIV vaccines in the United States.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0376-8716
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
127-31
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12927650-Adult,
pubmed-meshheading:12927650-Chi-Square Distribution,
pubmed-meshheading:12927650-Community-Institutional Relations,
pubmed-meshheading:12927650-Confidence Intervals,
pubmed-meshheading:12927650-Female,
pubmed-meshheading:12927650-Hepatitis B Vaccines,
pubmed-meshheading:12927650-Humans,
pubmed-meshheading:12927650-Logistic Models,
pubmed-meshheading:12927650-Male,
pubmed-meshheading:12927650-Middle Aged,
pubmed-meshheading:12927650-Motivation,
pubmed-meshheading:12927650-Odds Ratio,
pubmed-meshheading:12927650-Patient Compliance,
pubmed-meshheading:12927650-Substance Abuse, Intravenous
|
pubmed:year |
2003
|
pubmed:articleTitle |
A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users.
|
pubmed:affiliation |
Urban Health Study, Department of Family and Community Medicine, University of California San Francisco, San Francisco, CA 94110, USA. karens@itsa.ucsf.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|